J. Exp. Med., Volume 187, Number 11, June 1, 1998 1921-1926

BRIEF DEFINITIVE REPORT:
Eliminating a Region of Respiratory Syncytial Virus Attachment Protein Allows Induction of Protective Immunity without Vaccine-enhanced Lung Eosinophilia

By Tim E. Sparer,^* Stephen Matthews,^* Tracy Hussell,^* Aaron J. Rae,^* Blanca Garcia-Barreno, Jose A. Melero, and Peter J.M. Openshaw^*

From the ^* Imperial College School of Medicine, National Heart and Lung Institute at St. Mary's, London, W2 1PG United Kingdom; and the  Centro Nacional de Biologìa Celular y Retrovirus, Instituto de Salud `Carlos III', Majadahonda, 28220, Madrid, Spain

In a murine model of respiratory syncytial virus disease, prior sensitization to the attachment glycoprotein (G) leads to pulmonary eosinophilia and enhanced illness. Three different approaches were taken to dissect the region of G responsible for enhanced disease and protection against challenge. First, mutant viruses, containing frameshifts that altered the COOH terminus of the G protein, were used to challenge mice sensitized by scarification with recombinant vaccinia virus (rVV) expressing wild-type G. Second, cDNA expressing these mutated G proteins were expressed by rVV and used to vaccinate mice before challenge with wild-type respiratory syncytial virus (RSV). These studies identified residues 193-205 to be responsible for G-induced weight loss and lung eosinophilia and showed that this region was not was not necessary for induction of protective immunity. Third, mice were sensitized using an rVV that expressed only amino acids 124-203 of the G protein. Upon RSV challenge, mice sensitized with this rVV developed enhanced weight loss and eosinophilia. This is the first time that a region within RSV (amino acids 193-203) has been shown to be responsible for induction of lung eosinophilia and disease enhancement. Moreover, we now show that it is possible to induce protective immunity with an altered G protein without inducing a pathological response.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Percopo, C. M., Qiu, Z., Phipps, S., Foster, P. S., Domachowske, J. B., Rosenberg, H. F. (2009). Pulmonary Eosinophils and Their Role in Immunopathologic Responses to Formalin-Inactivated Pneumonia Virus of Mice. J. Immunol. 183: 604-612 [Abstract] [Full Text]  
• Wertheim, J. O., Worobey, M. (2009). Relaxed Selection and the Evolution of RNA Virus Mucin-Like Pathogenicity Factors. J. Virol. 83: 4690-4694 [Abstract] [Full Text]  
• Yu, J.-R., Kim, S., Lee, J.-B., Chang, J. (2008). Single Intranasal Immunization with Recombinant Adenovirus-Based Vaccine Induces Protective Immunity against Respiratory Syncytial Virus Infection. J. Virol. 82: 2350-2357 [Abstract] [Full Text]  
• Olson, M. R., Varga, S. M. (2007). CD8 T Cells Inhibit Respiratory Syncytial Virus (RSV) Vaccine-Enhanced Disease. J. Immunol. 179: 5415-5424 [Abstract] [Full Text]  
• Janssen, R., Pennings, J., Hodemaekers, H., Buisman, A., van Oosten, M., de Rond, L., Ozturk, K., Dormans, J., Kimman, T., Hoebee, B. (2007). Host Transcription Profiles upon Primary Respiratory Syncytial Virus Infection. J. Virol. 81: 5958-5967 [Abstract] [Full Text]  
• Lukacs, N. W., Moore, M. L., Rudd, B. D., Berlin, A. A., Collins, R. D., Olson, S. J., Ho, S. B., Peebles, R. S. Jr (2006). Differential Immune Responses and Pulmonary Pathophysiology Are Induced by Two Different Strains of Respiratory Syncytial Virus. Am. J. Pathol. 169: 977-986 [Abstract] [Full Text]  
• Bukreyev, A., Serra, M. E., Laham, F. R., Melendi, G. A., Kleeberger, S. R., Collins, P. L., Polack, F. P. (2006). The Cysteine-Rich Region and Secreted Form of the Attachment G Glycoprotein of Respiratory Syncytial Virus Enhance the Cytotoxic T-Lymphocyte Response despite Lacking Major Histocompatibility Complex Class I-Restricted Epitopes.. J. Virol. 80: 5854-5861 [Abstract] [Full Text]  
• Openshaw, P. J. M. (2005). Antiviral Immune Responses and Lung Inflammation after Respiratory Syncytial Virus Infection. Proc Am Thorac Soc 2: 121-125 [Abstract] [Full Text]  
• Openshaw, P. J. M., Tregoning, J. S. (2005). Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection. Clin. Microbiol. Rev. 18: 541-555 [Abstract] [Full Text]  
• Huang, Y., Anderson, R. (2005). Modulation of Protective Immunity, Eosinophilia, and Cytokine Responses by Selective Mutagenesis of a Recombinant G Protein Vaccine against Respiratory Syncytial Virus. J. Virol. 79: 4527-4532 [Abstract] [Full Text]  
• Matthews, S. P., Tregoning, J. S., Coyle, A. J., Hussell, T., Openshaw, P. J. M. (2005). Role of CCL11 in Eosinophilic Lung Disease during Respiratory Syncytial Virus Infection. J. Virol. 79: 2050-2057 [Abstract] [Full Text]  
• Elliott, M. B., Pryharski, K. S., Yu, Q., Boutilier, L. A., Campeol, N., Melville, K., Laughlin, T. S., Gupta, C. K., Lerch, R. A., Randolph, V. B., LaPierre, N. A., Dack, K. M. H., Hancock, G. E. (2004). Characterization of Recombinant Respiratory Syncytial Viruses with the Region Responsible for Type 2 T-Cell Responses and Pulmonary Eosinophilia Deleted from the Attachment (G) Protein. J. Virol. 78: 8446-8454 [Abstract] [Full Text]  
• Johnson, T. R., Varga, S. M., Braciale, T. J., Graham, B. S. (2004). V{beta}14+ T Cells Mediate the Vaccine-Enhanced Disease Induced by Immunization with Respiratory Syncytial Virus (RSV) G Glycoprotein but Not with Formalin-Inactivated RSV. J. Virol. 78: 8753-8760 [Abstract] [Full Text]  
• Elliott, M. B., Pryharski, K. S., Yu, Q., Parks, C. L., Laughlin, T. S., Gupta, C. K., Lerch, R. A., Randolph, V. B., LaPierre, N. A., Dack, K. M. H., Hancock, G. E. (2004). Recombinant Respiratory Syncytial Viruses Lacking the C-Terminal Third of the Attachment (G) Protein Are Immunogenic and Attenuated In Vivo and In Vitro. J. Virol. 78: 5773-5783 [Abstract] [Full Text]  
• Johnson, T. R., Teng, M. N., Collins, P. L., Graham, B. S. (2004). Respiratory Syncytial Virus (RSV) G Glycoprotein Is Not Necessary for Vaccine-Enhanced Disease Induced by Immunization with Formalin-Inactivated RSV. J. Virol. 78: 6024-6032 [Abstract] [Full Text]  
• Peret, T. C. T., Abed, Y., Anderson, L. J., Erdman, D. D., Boivin, G. (2004). Sequence polymorphism of the predicted human metapneumovirus G glycoprotein. J. Gen. Virol. 85: 679-686 [Abstract] [Full Text]  
• Haynes, L. M., Jones, L. P., Barskey, A., Anderson, L. J., Tripp, R. A. (2003). Enhanced Disease and Pulmonary Eosinophilia Associated with Formalin-Inactivated Respiratory Syncytial Virus Vaccination Are Linked to G Glycoprotein CX3C-CX3CR1 Interaction and Expression of Substance P. J. Virol. 77: 9831-9844 [Abstract] [Full Text]  
• Tripp, R. A., Dakhama, A., Jones, L. P., Barskey, A., Gelfand, E. W., Anderson, L. J. (2003). The G Glycoprotein of Respiratory Syncytial Virus Depresses Respiratory Rates through the CX3C Motif and Substance P. J. Virol. 77: 6580-6584 [Abstract] [Full Text]  
• Johnson, T. R., Parker, R. A., Johnson, J. E., Graham, B. S. (2003). IL-13 Is Sufficient for Respiratory Syncytial Virus G Glycoprotein-Induced Eosinophilia After Respiratory Syncytial Virus Challenge. J. Immunol. 170: 2037-2045 [Abstract] [Full Text]  
• Culley, F. J., Pollott, J., Openshaw, P. J.M. (2002). Age at First Viral Infection Determines the Pattern of T Cell-mediated Disease during Reinfection in Adulthood. JEM 196: 1381-1386 [Abstract] [Full Text]  
• Saarelainen, S., Zeiler, T., Rautiainen, J., Narvanen, A., Rytkonen-Nissinen, M., Mantyjarvi, R., Vilja, P., Virtanen, T. (2002). Lipocalin allergen Bos d 2 is a weak immunogen. Int Immunol 14: 401-409 [Abstract] [Full Text]  
• Durbin, J. E., Johnson, T. R., Durbin, R. K., Mertz, S. E., Morotti, R. A., Peebles, R. S., Graham, B. S. (2002). The Role of IFN in Respiratory Syncytial Virus Pathogenesis. J. Immunol. 168: 2944-2952 [Abstract] [Full Text]  
• Holt, P.G., Sly, P.D. (2002). Interactions between respiratory tract infections and atopy in the aetiology of asthma. Eur Respir J 19: 538-545 [Abstract] [Full Text]  
• Boyton, R. J, Openshaw, P. J (2002). Pulmonary defences to acute respiratory infection. Br Med Bull 61: 1-12 [Abstract] [Full Text]  
• McNamara, P. S, Smyth, R. L (2002). The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull 61: 13-28 [Abstract] [Full Text]  
• Prince, G. A., Curtis, S. J., Yim, K. C., Porter, D. D. (2001). Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. J. Gen. Virol. 82: 2881-2888 [Abstract] [Full Text]  
• Johnson, T. R., Fischer, J. E., Graham, B. S. (2001). Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine. J. Gen. Virol. 82: 2107-2116 [Abstract] [Full Text]  
• Schmidt, A. C., McAuliffe, J. M., Murphy, B. R., Collins, P. L. (2001). Recombinant Bovine/Human Parainfluenza Virus Type 3 (B/HPIV3) Expressing the Respiratory Syncytial Virus (RSV) G and F Proteins Can Be Used To Achieve Simultaneous Mucosal Immunization against RSV and HPIV3. J. Virol. 75: 4594-4603 [Abstract] [Full Text]  
• Simmons, C. P., Hussell, T., Sparer, T., Walzl, G., Openshaw, P., Dougan, G. (2001). Mucosal Delivery of a Respiratory Syncytial Virus CTL Peptide with Enterotoxin-Based Adjuvants Elicits Protective, Immunopathogenic, and Immunoregulatory Antiviral CD8+ T Cell Responses. J. Immunol. 166: 1106-1113 [Abstract] [Full Text]  
• Hussell, T., Openshaw, P. J. M. (2000). IL-12-Activated NK Cells Reduce Lung Eosinophilia to the Attachment Protein of Respiratory Syncytial Virus But Do Not Enhance the Severity of Illness in CD8 T Cell-Immunodeficient Conditions. J. Immunol. 165: 7109-7115 [Abstract] [Full Text]  
• Varga, S. M., Wissinger, E. L., Braciale, T. J. (2000). The Attachment (G) Glycoprotein of Respiratory Syncytial Virus Contains a Single Immunodominant Epitope That Elicits Both Th1 and Th2 CD4+ T Cell Responses. J. Immunol. 165: 6487-6495 [Abstract] [Full Text]  
• Valarcher, J.-F., Schelcher, F., Bourhy, H. (2000). Evolution of Bovine Respiratory Syncytial Virus. J. Virol. 74: 10714-10728 [Abstract] [Full Text]  
• Goulder, P. J. R., Lechner, F., Klenerman, P., McIntosh, K., Walker, B. D. (2000). Characterization of a Novel Respiratory Syncytial Virus-Specific Human Cytotoxic T-Lymphocyte Epitope. J. Virol. 74: 7694-7697 [Abstract] [Full Text]  
• Plotnicky-Gilquin, H., Robert, A., Chevalet, L., Haeuw, J.-F., Beck, A., Bonnefoy, J.-Y., Brandt, C., Siegrist, C.-A., Nguyen, T. N., Power, U. F. (2000). CD4+ T-Cell-Mediated Antiviral Protection of the Upper Respiratory Tract in BALB/c Mice following Parenteral Immunization with a Recombinant Respiratory Syncytial Virus G Protein Fragment. J. Virol. 74: 3455-3463 [Abstract] [Full Text]  
• Tripp, R. A., Moore, D., Winter, J., Anderson, L. J. (2000). Respiratory Syncytial Virus Infection and G and/or SH Protein Expression Contribute to Substance P, Which Mediates Inflammation and Enhanced Pulmonary Disease in BALB/c Mice. J. Virol. 74: 1614-1622 [Abstract] [Full Text]  
• Johnson, T. R., Graham, B. S. (1999). Secreted Respiratory Syncytial Virus G Glycoprotein Induces Interleukin-5 (IL-5), IL-13, and Eosinophilia by an IL-4-Independent Mechanism. J. Virol. 73: 8485-8495 [Abstract] [Full Text]  
• Tripp, R. A., Moore, D., Jones, L., Sullender, W., Winter, J., Anderson, L. J. (1999). Respiratory Syncytial Virus G and/or SH Protein Alters Th1 Cytokines, Natural Killer Cells, and Neutrophils Responding to Pulmonary Infection in BALB/c Mice. J. Virol. 73: 7099-7107 [Abstract] [Full Text]  
• Srikiatkhachorn, A., Chang, W., Braciale, T. J. (1999). Induction of Th-1 and Th-2 Responses by Respiratory Syncytial Virus Attachment Glycoprotein Is Epitope and Major Histocompatibility Complex Independent. J. Virol. 73: 6590-6597 [Abstract] [Full Text]  
• Feldman, S. A., Hendry, R. M., Beeler, J. A. (1999). Identification of a Linear Heparin Binding Domain for Human Respiratory Syncytial Virus Attachment Glycoprotein G. J. Virol. 73: 6610-6617 [Abstract] [Full Text]  
• Hsu, S., Chargelegue, D, Obeid, O., Steward, M. (1999). Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus. J. Gen. Virol. 80: 1401-1405 [Abstract]  
• Tebbey, P. W., Hagen, M., Hancock, G. E. (1998). Atypical Pulmonary Eosinophilia Is Mediated by a Specific Amino Acid Sequence of the Attachment (G) Protein of Respiratory Syncytial Virus. JEM 188: 1967-1972 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS